AbCellera Biologics Inc (ABCL) Q3 2025 Earnings Call Highlights: Transition to Clinical-Stage ...

AbCellera Biologics Inc (ABCL) Q3 2025 Earnings Call Highlights: Transition to Clinical-Stage …

This article first appeared on GuruFocus. Release Date: November 06, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. AbCellera Biologics Inc (NASDAQ:ABCL) has successfully transitioned from a platform company to a clinical-stage biotech, with phase one clinical trials for ABCL 635 and ABCL 575 underway. The…

Read More
Trump Says China Tariffs “Not Sustainable” Amid Ongoing Trade Tensions, Markets React — TradingView News

US Stocks Lower — TradingView News

US stocks fell sharply on Thursday, with the S&P 500 dropping 0.9%, the Nasdaq falling 1.5%, and the Dow Jones sliding nearly 400 points, weighed down by declines in consumer discretionary and tech shares. Renewed concerns over stretched AI-related stock valuations resurfaced amid mixed earnings reports. At the same time, worries about a sharper cooling…

Read More